BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33063192)

  • 1. Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease.
    Karaskova E; Pospisilova D; Velganova-Veghova M; Geryk M; Volejnikova J; Holub D; Hajduch M
    Dig Dis Sci; 2021 Oct; 66(10):3263-3269. PubMed ID: 33063192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of hepcidin in iron metabolism in inflammatory bowel diseases].
    Krawiec P; Pac-Kozuchowska E
    Postepy Hig Med Dosw (Online); 2014; 68():936-43. PubMed ID: 24988613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and hepcidin: a story of recycling and balance.
    Camaschella C
    Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
    Nemeth E; Ganz T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
    Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
    Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin and its role in inflammatory bowel disease.
    Dudkowiak R; Neubauer K; Poniewierka E
    Adv Clin Exp Med; 2013; 22(4):585-91. PubMed ID: 23986220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on iron physiology.
    Muñoz M; Villar I; García-Erce JA
    World J Gastroenterol; 2009 Oct; 15(37):4617-26. PubMed ID: 19787824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin and iron homeostasis.
    Ganz T; Nemeth E
    Biochim Biophys Acta; 2012 Sep; 1823(9):1434-43. PubMed ID: 22306005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulators of hepcidin expression.
    Roth MP; Meynard D; Coppin H
    Vitam Horm; 2019; 110():101-129. PubMed ID: 30798807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepcidin-ferroportin axis in the pathophysiology, diagnosis, and treatment of anemia of chronic inflammation.
    Langer AL; Ginzburg YZ
    Hemodial Int; 2017 Jun; 21 Suppl 1(Suppl 1):S37-S46. PubMed ID: 28328181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling Systemic Iron Regulation during Dietary Iron Overload and Acute Inflammation: Role of Hepcidin-Independent Mechanisms.
    Enculescu M; Metzendorf C; Sparla R; Hahnel M; Bode J; Muckenthaler MU; Legewie S
    PLoS Comput Biol; 2017 Jan; 13(1):e1005322. PubMed ID: 28068331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of hepcidin and iron-overload disease.
    Lee PL; Beutler E
    Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Absorption in Celiac Disease and Nutraceutical Effect of 7-Hydroxymatairesinol. Mini-Review.
    Zanella I; Paiardi G; Di Lorenzo D; Biasiotto G
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32349426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peering into the future: hepcidin testing.
    Goyal J; McCleskey B; Adamski J
    Am J Hematol; 2013 Nov; 88(11):976-8. PubMed ID: 23798368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis of iron overload disorders and iron-linked anemias.
    Kaplan J; Ward DM; De Domenico I
    Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin.
    Tussing-Humphreys L; Pusatcioglu C; Nemeth E; Braunschweig C
    J Acad Nutr Diet; 2012 Mar; 112(3):391-400. PubMed ID: 22717199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
    Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
    Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin in chronic kidney disease anemia.
    Santos-Silva A; Ribeiro S; Reis F; Belo L
    Vitam Horm; 2019; 110():243-264. PubMed ID: 30798815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.